Healthcare -
Biotechnology - NASDAQ - US
$ 11.6375
5.89 %
$ 616 M
Market Cap
-5.59
P/E
STOK - OPERATING EXPENSES
Operating Expenses STOK - Stoke Therapeutics, Inc.
124 M
LAST VALUE
19.82%
2 YEAR CAGR
57.42%
5 YEAR CAGR
0.00%
10 YEAR CAGR